Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A New era for European Respiratory Society clinical practice guidelines: joining efficiency and high methodological standards. PMID: 29519905 Journal: EUROPEAN RESPIRATORY JOURNAL Year: 2018 Reference: Eur Respir J. 2018 Mar 8;51(3). pii: 51/3/1800221. doi: 10.1183/13993003.00221-2018. Print 2018 Mar. Impact factor: Publication type: Editorail in international publication Authors: Brusselle, Guy; Gaga, Mina; Genton, Celine; Miravitlles, Marc; Rigau, David; Roche, Nicolas; Tonia, Thomy; Vaccaro, Valerie; Welte, Tobias et al. DOI: 10.1183/13993003.00221-2018 New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation. PMID: 29358640 Journal: Scientific Reports Year: 2018 Reference: Sci Rep. 2018 Jan 22;8(1):1381. doi: 10.1038/s41598-018-19794-0. Impact factor: 4.122 Publication type: Paper in international publication Authors: Mata, Agata, Gil, Vanessa, Perez-Clausell, Jeus, Dasilva, Miguel, Gonzalez-Calixto, Mari Carmen, Soriano, Eduardo, Garcia-Verdugo, Jose Manuel, Sanchez-Vives, Maria V, Del Rio, Jose Antonio et al. DOI: 10.1038/s41598-018-19794-0 New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation. PMID: 29358640 Journal: Scientific Reports Year: 2018 Reference: Sci Rep. 2018 Jan 22;8(1):1381. doi: 10.1038/s41598-018-19794-0. Impact factor: Publication type: Paper in international publication Authors: Dasilva, Miguel; Del Rio, Jose Antonio; Garcia-Verdugo, Jose Manuel; Gil, Vanessa; Gonzalez-Calixto, Mari Carmen; Mata, Agata; Perez-Clausell, Jeus; Sanchez-Vives, Maria V; Soriano, Eduardo et al. DOI: 10.1038/s41598-018-19794-0 New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors. PMID: 29239718 Journal: JOURNAL OF GENERAL VIROLOGY Year: 2018 Reference: J Gen Virol. 2018 Jan;99(1):97-102. doi: 10.1099/jgv.0.000996. Epub 2017 Dec 14. Impact factor: 2.514 Publication type: Paper in international publication Authors: Chen, Qian, Riveiro-Barciela, Mar, Buti, Maria, Esteban, Rafael, Esteban, Juan Ignacio, Rodriguez-Frias, Francisco, Quer, Josep, Llorens, Meritxell, Perales, Celia, Soria, Maria Eugenia et al. DOI: 10.1099/jgv.0.000996 New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors. PMID: 29239718 Journal: JOURNAL OF GENERAL VIROLOGY Year: 2018 Reference: J Gen Virol. 2018 Jan;99(1):97-102. doi: 10.1099/jgv.0.000996. Epub 2017 Dec 14. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Chen, Qian; Esteban, Juan Ignacio; Esteban, Rafael; Garcia-Cehic, Damir; Gregori, Josep; Llorens, Meritxell; Nieto-Aponte, Leonardo; Ordeig, Laura; Perales, Celia et al. DOI: 10.1099/jgv.0.000996 News from ASCO 2018. PMID: 30319333 Journal: Breast Care Year: 2018 Reference: Breast Care (Basel). 2018 Aug;13(4):298-302. doi: 10.1159/000491564. Epub 2018 Jul 12. Impact factor: 2.028 Publication type: Letter or abstract Authors: Gampenrieder, Simon, Balic, Marija, Dedic, Natalija, De Mattos-Arruda, Leticia et al. DOI: 10.1159/000491564 News from ASCO 2018. PMID: 30319333 Journal: Breast Care Year: 2018 Reference: Breast Care (Basel). 2018 Aug;13(4):298-302. doi: 10.1159/000491564. Epub 2018 Jul 12. Impact factor: Publication type: Letter or abstract Authors: Balic, Marija; De Mattos-Arruda, Leticia; Dedic, Natalija; Gampenrieder, Simon et al. DOI: 10.1159/000491564 Nilotinib as co-adjuvant treatment with doxorubicin in patients with sarcomas: A phase I trial of the Spanish Group for Research on Sarcoma. PMID: 30037815 Journal: CLINICAL CANCER RESEARCH Year: 2018 Reference: Clin Cancer Res. 2018 Nov 1;24(21):5239-5249. doi: 10.1158/1078-0432.CCR-18-0851. Epub 2018 Jul 23. Impact factor: 10.199 Publication type: Clinical Trials Authors: Alemany, Regina, Moura, David S, Redondo, Andres, Martinez-Trufero, Javier, Calabuig, Silvia, Saus, Carles, Obrador-Hevia, Antonia, Ramos, Rafael F, Villar, Victor H, Valverde, Claudia et al. DOI: 10.1158/1078-0432.CCR-18-0851 Nilotinib as co-adjuvant treatment with doxorubicin in patients with sarcomas: A phase I trial of the Spanish Group for Research on Sarcoma. PMID: 30037815 Journal: CLINICAL CANCER RESEARCH Year: 2018 Reference: Clin Cancer Res. 2018 Nov 1;24(21):5239-5249. doi: 10.1158/1078-0432.CCR-18-0851. Epub 2018 Jul 23. Impact factor: Publication type: Clinical Trials Authors: Alemany, Regina; Calabuig, Silvia; Felipe-Abrio, Irene; Hindi, Nadia; Martin-Broto, Javier; Martinez-Trufero, Javier; Medina, Javier; Moura, David S; Obrador-Hevia, Antonia; Ramos, Rafael F et al. DOI: 10.1158/1078-0432.CCR-18-0851 Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. PMID: 30010751 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Sep 1;29(9):1955-1963. doi: 10.1093/annonc/mdy241. Impact factor: 13.926 Publication type: Paper in international publication Authors: Lonardi, S, Van Cutsem, E, Yoshino, T, Lenz, H J, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J et al. DOI: 10.1093/annonc/mdy241 Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. PMID: 30010751 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Sep 1;29(9):1955-1963. doi: 10.1093/annonc/mdy241. Impact factor: Publication type: Paper in international publication Authors: Argiles, G; Ciardiello, F; Falcone, A; Ferreiro, R; Hong, Y S; Lenz, H J; Limon, M L; Lonardi, S; Oum'Hamed, Z; Park, Y S et al. DOI: 10.1093/annonc/mdy241 Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. PMID: 30220235 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2018 Reference: N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15. Impact factor: 79.258 Publication type: Paper in international publication Authors: Glaspole, I, Kolb, Martin, Raghu, Ganesh, Wells, Athol U, Behr, Jurgen, Richeldi, Luca, Schinzel, Birgit, Quaresma, Manuel, Stowasser, Susanne, Martinez, Fernando J et al. DOI: 10.1056/NEJMoa1811737 Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. PMID: 30220235 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2018 Reference: N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15. Impact factor: Publication type: Paper in international publication Authors: Adamali, H; Baba, T; Balestro, E; Behr, Jurgen; Bianchi, S; Bollmann, T; Bondue, B; Bonella, F; Bourdin, A; Church, C et al. DOI: 10.1056/NEJMoa1811737 Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. PMID: 29408986 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041. Impact factor: 13.926 Publication type: Paper in international publication Authors: Gettinger, S, Vokes, E E, Ready, N, Felip, E, Horn, L, Burgio, M A, Antonia, S J, Aren Frontera, O, Waterhouse, D, Domine, M et al. DOI: 10.1093/annonc/mdy041 Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases. PMID: 29408986 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041. Impact factor: Publication type: Paper in international publication Authors: Antonia, S J; Aren Frontera, O; Arrieta, O; Barlesi, F; Blumenschein, G Jr; Brahmer, J; Burgio, M A; Butts, C; Chow, L Q M; Coudert, B et al. DOI: 10.1093/annonc/mdy041 NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients. PMID: 29117789 Journal: Multiple Sclerosis Journal Year: 2018 Reference: Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9. Impact factor: 5.28 Publication type: Paper in international publication Authors: Malhotra, Sunny, Sorosina, Melissa, Rio, Jordi, Peroni, Silvia, Midaglia, Luciana, Villar, Luisa M, Alvarez-Cermeno, Jose C, Schroeder, Ina, Esposito, Federica, Clarelli, Ferdinando et al. DOI: 10.1177/1352458517739137 NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients. PMID: 29117789 Journal: Multiple Sclerosis Journal Year: 2018 Reference: Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9. Impact factor: Publication type: Paper in international publication Authors: Alvarez-Cermeno, Jose C; Clarelli, Ferdinando; Comabella, Manuel; Comi, Giancarlo; Esposito, Federica; Lechner-Scott, Jeannette; Malhotra, Sunny; Martinelli-Boneschi, Filippo; Midaglia, Luciana; Montalban, Xavier et al. DOI: 10.1177/1352458517739137 No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B. PMID: 30038044 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2018 Reference: Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: AAC.01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct. Impact factor: 4.255 Publication type: Paper in international publication Authors: Buti, Maria, Cox, Stephanie, Parhy, Bandita, Zhou, Eric, Martin, Ross, Chang, Silvia, Lin, Lanjia, Flaherty, John F, Kitrinos, Kathryn M, Gaggar, Anuj et al. DOI: 10.1128/AAC.01064-18 No Resistance to Tenofovir Alafenamide Detected Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B. PMID: 30038044 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2018 Reference: Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: AAC.01064-18. doi: 10.1128/AAC.01064-18. Print 2018 Oct. Impact factor: Publication type: Paper in international publication Authors: Bhardwaj, Neeru; Buti, Maria; Cathcart, Andrea L; Chan, Henry Lik-Yuen; Chang, Silvia; Cox, Stephanie; Flaherty, John F; Gaggar, Anuj; Izumi, Namiki; Kitrinos, Kathryn M et al. DOI: 10.1128/AAC.01064-18 Non traumatic giant aneurysm of middle meningeal artery. Case report and review of the literature. PMID: 29292165 Journal: NEUROCIRUGIA Year: 2018 Reference: Neurocirugia (Astur). 2018 Sep - Oct;29(5):250-254. doi: 10.1016/j.neucir.2017.11.003. Epub 2017 Dec 29. Impact factor: 0.31 Publication type: Paper in national publication Authors: Vilalta, Jordi, Martinez-Ricarte, Francisco, Martinez-Saez, Elena A, Gandara, Dario, Arikan, Fuat et al. DOI: 10.1016/j.neucir.2017.11.003 Non traumatic giant aneurysm of middle meningeal artery. Case report and review of the literature. PMID: 29292165 Journal: NEUROCIRUGIA Year: 2018 Reference: Neurocirugia (Astur). 2018 Sep - Oct;29(5):250-254. doi: 10.1016/j.neucir.2017.11.003. Epub 2017 Dec 29. Impact factor: Publication type: Paper in national publication Authors: Arikan, Fuat; Gandara, Dario; Martinez-Ricarte, Francisco; Martinez-Saez, Elena A; Vilalta, Jordi et al. DOI: 10.1016/j.neucir.2017.11.003 Non-Commercial versus Commercial Clinical Trials: a Retrospective Study of the Applications Submitted to a Research Ethics Committee. PMID: 29446851 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2018 Reference: Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22. Impact factor: 3.838 Publication type: Paper in international publication Authors: Fuentes Camps, Inmaculada, Rodriguez, Alexis, Agusti, Antonia et al. DOI: 10.1111/bcp.13555 Non-Commercial versus Commercial Clinical Trials: a Retrospective Study of the Applications Submitted to a Research Ethics Committee. PMID: 29446851 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2018 Reference: Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22. Impact factor: Publication type: Paper in international publication Authors: Agusti, Antonia; Fuentes Camps, Inmaculada; Rodriguez, Alexis et al. DOI: 10.1111/bcp.13555 Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. PMID: 29697741 Journal: ANNALS OF ONCOLOGY Year: 2018 Reference: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18. doi: 10.1093/annonc/mdy001. Impact factor: 13.926 Publication type: Paper in international publication Authors: Ray-Coquard, I, Morice, P, Lorusso, D, Prat, J, Oaknin, A, Pautier, P, Colombo, N et al. DOI: 10.1093/annonc/mdy001 Pagination First page « First Previous page ‹ Previous … Page 891 Page 892 Page 893 Page 894 Current page 895 Page 896 Page 897 Page 898 Page 899 … Next page Next › Last page Last »
